Dafna Capital Management LLC Syndax Pharmaceuticals Inc Transaction History

Dafna Capital Management LLC

$390 Million
Q2 2024

A detailed history of Dafna Capital Management LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Dafna Capital Management LLC holds 657,074 shares of SNDX stock, worth $12.4 Million. This represents 3.46% of its overall portfolio holdings.

Number of Shares

657,074

Previous 659,574 0.38%

Holding current value

$12.4 Million

Previous $15.7 Million 14.07%

% of portfolio

3.46%

Previous 3.78%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$18.82 - $23.79 $47,050 - $59,475	-2,500 Reduced 0.38%	657,074 $13.5 Million
Q1 2024 May 15, 2024	SELL	$19.71 - $24.57 $1.64 Million - $2.04 Million	-83,000 Reduced 11.18%	659,574 $15.7 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $3.24 Million - $6.16 Million	284,201 Added 62.0%	742,574 $16 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $108,900 - $163,275	7,500 Added 1.66%	458,373 $6.66 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $73,530 - $84,778	3,800 Added 0.85%	450,873 $9.44 Million
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $1.89 Million - $2.4 Million	91,586 Added 25.76%	447,073 $11.4 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $286,905 - $384,245	-15,500 Reduced 4.18%	355,487 $8.54 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $13,640 - $19,480	-1,000 Reduced 0.27%	370,987 $7.14 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $1.12 Million - $1.67 Million	75,452 Added 25.44%	371,987 $6.47 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $3.29 Million - $4.85 Million	215,833 Added 267.44%	296,535 $6.49 Million
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $929,290 - $1.33 Million	-67,000 Reduced 45.36%	80,702 $1.54 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $1.21 Million - $2.27 Million	90,202 Added 156.87%	147,702 $2.54 Million
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $915,800 - $1.17 Million	47,500 Added 475.0%	57,500 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$15.1 - $26.44 $1.4 Million - $2.45 Million	-92,713 Reduced 90.26%	10,000 $222,000
Q3 2020 Nov 16, 2020	SELL	$13.39 - $17.48 $3.45 Million - $4.5 Million	-257,287 Reduced 71.47%	102,713 $1.52 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $3.22 Million - $7.55 Million	360,000 New	360,000 $5.34 Million

Others Institutions Holding SNDX

# of Institutions

202

Shares Held

87.1M

Call Options Held

268K

Put Options Held

76.8K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.07B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Syndax Pharmaceuticals Inc Transaction History